Navigation Links
Queensland scientists identify molecule that links both sides of the brain

A Queensland Brain Institute-led team has identified a molecule that plays a key role in establishing the major nerve connections between each side of the adult brain.

QBI neural migration laboratory head Associate Professor Helen Cooper said her group's research provided new clues regarding development of the corpus callosum, the main connecting nerve tract that shuttles information between the left and right hemispheres of the adult brain.

Using a mouse model, neuroscientists at The University of Queensland ?working with Associate Professor Steven Stacker and his team at the Ludwig Institute for Cancer Research in Melbourne ?have identified a molecule that helps control development of the corpus callosum.

The corpus callosum has millions of individual nerve fibres. If these fibres fail to reach their correct targets in the opposite hemisphere, people can suffer from epilepsy, and experience some degree of mental retardation.

"Our study is the first to identify a growth molecule that guides young nerves away from the corpus callosum and towards their targets in the opposite hemisphere," Dr Cooper said.

"We have shown that the Ryk receptor molecule facilitates the targeting of individual nerve fibres.

"This process is critical for the transmission of sensory information effectively throughout the adult brain."

These findings are expected to have long-term implications for development of treatments for several forms of mental impairment and epilepsy.

A QBI-led scientific paper outlining functions of the Ryk receptor molecule is published in the May 24 edition of The Journal of Neuroscience.

QBI has been studying a variety of molecular guidance systems which play pivotal roles in the guidance of nerve fibres and newly born neurons throughout the developing central nervous system.


'"/>

Source:Research Australia


Page: 1

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: